ARCH CAPITAL GROUP LTD. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ARCH CAPITAL GROUP LTD. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.93B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $17.44B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $13.63B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $9.61B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $9.25B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $8.51B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $6.93B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $5.45B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $5.63B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $4.46B | Feb 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.40B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.44B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.48B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.16B | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | $543.54M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $419.04M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $298.82M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $144.12M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $326.38M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.17B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.67B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.75B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.82B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $3.43B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $2.89B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $2.05B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.56B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.09B | Feb 28, 2020 |
| FY2013 | Dec 31, 2013 | $850.87M | Mar 3, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.24B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $70.91B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $58.91B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $47.99B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $45.10B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $43.28B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $37.89B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $32.22B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $32.05B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $29.37B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.04B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $50.09B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $40.55B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $35.07B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $31.55B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $29.29B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $25.57B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $21.78B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $21.81B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $20.06B | Feb 28, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.21B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $20.82B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $18.35B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $12.91B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $13.55B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $13.11B | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $11.50B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $9.44B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $9.20B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $8.25B | Feb 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $607.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $571.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $345.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $342.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $345.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $314.63M | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $326.55M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $249.62M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $198.24M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $204.02M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $22.69B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $20.30B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $15.89B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $14.46B | Feb 24, 2023 |
| FY2020 | Dec 31, 2020 | $12.36B | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | $11.02B | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | $9.43B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $8.56B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $8.00B | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $993.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $979.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $917.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $855.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $859.00M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $906.45M | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | $726.23M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $646.56M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $606.20M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $842.94M | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 11 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 11 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 23, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 26, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 359.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 376.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 373.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 370.40M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 378.90M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 406.72M | Feb 24, 2023 |
| FY2020 | Dec 31, 2019 | 405.62M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 402.45M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 392.93M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | 368.36M | Feb 28, 2019 |